INDERIDE-80/25 |
AY-64043- |
INDERIDE-40/25 |
INDERAL |
PROPRANOLOL |
Drug Categories | phenoxypropanolamines |
Drug Class | anti-arrhythmia agents |
Drug Class | antihypertensive agents |
Year of Approval | 1967 |
FDA Approval | approved |
Drug Class | Small Molecule |
Drug Indications | for treatment of cancer cachexia |
Drug Categories | agents causing hyperkalemia |
Drug Categories | antiarrhythmic agents |
Drug Categories | antihypertensive agents indicated for hypertension |
Drug Categories | beta blocking agents and thiazides |
Drug Categories | beta blocking agents, non-selective |
Drug Categories | beta blocking agents, non-selective, and thiazides |
Drug Categories | cytochrome p-450 cyp3a substrates |
Drug Categories | cytochrome p-450 cyp3a5 substrates |
Drug Categories | cytochrome p-450 cyp3a7 substrates |
Drug Categories | cytochrome p-450 enzyme inhibitors |
Drug Categories | cytochrome p-450 substrates |
Drug Categories | drugs that are mainly renally excreted |
Drug Categories | moderate risk qtc-prolonging agents |
Drug Categories | monoamine oxidase a inhibitors for interaction with monoamine oxidase a substrates |
Drug Categories | oct2 inhibitors |
Drug Categories | p-glycoprotein inhibitors |
Drug Categories | p-glycoprotein substrates |
Drug Categories | qtc prolonging agents |
Drug Categories | vasodilating agents |
antagonist (inhibitory) |
Specific Action of the Ligand | Antagonist |
Endogenous Drug? | False |
Direct Interaction? | True |
525-66-6 | CAS Number |
Angilol | Drug Brand |
Apo Propranolol Tab 10mg | Drug Brand |
Drug Type | small molecule |
Drug Groups | approved |
Drug Groups | investigational |
Drug Indications | for treatment of cancer cachexia |
Drug Class | Small Molecule |
FDA Approval | approved |
Year of Approval | 1967 |
Drug Class | antihypertensive agents |
Drug Class | anti-arrhythmia agents |
CHEMBL27 | ChEMBL Drug ID |
C29382 | NCI drug code |
D04JEE | TTD Drug ID |